PCI BIOTECH HOLDING ASA (PCIB.OL) Stock Price, Quote, News and Overview
OSL:PCIB - Euronext Oslo - NO0010405640 - Common Stock - Currency: NOK
PCIB.OL Quote, Performance and Key Statistics
OSL:PCIB (5/5/2025, 7:00:00 PM)
1.5
+0.11 (+7.91%)
The current stock price of PCIB.OL is 1.5 NOK. In the past month the price increased by 4.79%. In the past year, price decreased by -8.44%.
PCIB.OL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.48 | 295.77B | ||
| 1ABBV.MI | ABBVIE INC | 18.36 | 294.00B | ||
| AMG.DE | AMGEN INC | 13.11 | 129.04B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 13.7 | 116.36B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.22 | 112.29B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | 1501.35 | 100.35B | ||
| ARGX.BR | ARGENX SE | 370.33 | 34.60B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 21.11B | ||
| IDP.DE | BIOGEN INC | 7.73 | 15.80B | ||
| 1MRNA.MI | MODERNA INC | N/A | 9.49B | ||
| 0QF.DE | MODERNA INC | N/A | 9.03B | ||
| BIO.DE | BIOTEST AG | 64.92 | 1.67B |
Related stock screener links
About PCIB.OL
Company Profile
PCI Biotech Holding ASA engages in the research and development of biopharmaceutical products for cancer treatment. The company is headquartered in Oslo, Oslo. The company went IPO on 2008-06-18. The firm is developing therapeutic products based on its photochemical internalisation (PCI) technology. PCI Biotech’s product is the photosensitiser fimaporfin (Amphinex). The PCI technology can enhance the effect of anticancer drugs by targeted, light-directed drug delivery into cancer cells, and can also be used as a platform that may both potentiate the effect of vaccines and enable macromolecules to reach intracellular targets. The PCI technology platform consists of two elements: a small molecule photosensitiser (named fimaporfin) and a light source. The primary aim of PCI is to introduce drug molecules or macromolecules into the cytosol of the target cells. The company is this drug or macromolecule that gives the biological effect in a PCI treatment, and the intended biological effect may range from cell killing, through modification of gene expression to enhanced antigen presentation.
Company Info
PCI BIOTECH HOLDING ASA
Ullernchauseen 64
Oslo OSLO NO
Employees: 5
Phone: 4767115400
PCI BIOTECH HOLDING ASA / PCIB.OL FAQ
What is the stock price of PCI BIOTECH HOLDING ASA today?
The current stock price of PCIB.OL is 1.5 NOK. The price increased by 7.91% in the last trading session.
What is the ticker symbol for PCI BIOTECH HOLDING ASA stock?
The exchange symbol of PCI BIOTECH HOLDING ASA is PCIB and it is listed on the Euronext Oslo exchange.
On which exchange is PCIB.OL stock listed?
PCIB.OL stock is listed on the Euronext Oslo exchange.
What is PCI BIOTECH HOLDING ASA worth?
PCI BIOTECH HOLDING ASA (PCIB.OL) has a market capitalization of 55.99M NOK. This makes PCIB.OL a Micro Cap stock.
How many employees does PCI BIOTECH HOLDING ASA have?
PCI BIOTECH HOLDING ASA (PCIB.OL) currently has 5 employees.
What are the support and resistance levels for PCI BIOTECH HOLDING ASA (PCIB.OL) stock?
PCI BIOTECH HOLDING ASA (PCIB.OL) has a support level at 1.48 and a resistance level at 1.5. Check the full technical report for a detailed analysis of PCIB.OL support and resistance levels.
Should I buy PCI BIOTECH HOLDING ASA (PCIB.OL) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PCIB.OL, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PCIB.OL, evaluating the profitability, health, valuation and growth aspects
- PCI BIOTECH HOLDING ASA (PCIB.OL) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PCI BIOTECH HOLDING ASA (PCIB.OL) Sales and EPS estimates to see what analysts future expectations are.
- PCI BIOTECH HOLDING ASA (PCIB.OL) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PCI BIOTECH HOLDING ASA (PCIB.OL) Insider and Institutional Ownership to learn about the owners and their transactions.
- PCI BIOTECH HOLDING ASA (PCIB.OL) Stock Chart to make your own analysis
- PCI BIOTECH HOLDING ASA (PCIB.OL) Latest news and press-releases to stay up to date.
Does PCI BIOTECH HOLDING ASA (PCIB.OL) stock pay dividends?
PCIB.OL does not pay a dividend.
What is the Price/Earnings (PE) ratio of PCI BIOTECH HOLDING ASA (PCIB.OL)?
PCI BIOTECH HOLDING ASA (PCIB.OL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.44).
PCIB.OL Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to PCIB.OL. When comparing the yearly performance of all stocks, PCIB.OL turns out to be only a medium performer in the overall market: it outperformed 64.52% of all stocks.
PCIB.OL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to PCIB.OL. PCIB.OL has a great financial health rating, but its profitability evaluates not so good.
PCIB.OL Financial Highlights
Over the last trailing twelve months PCIB.OL reported a non-GAAP Earnings per Share(EPS) of -0.44. The EPS increased by 19.2% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -52.59% | ||
| ROE | -70% | ||
| Debt/Equity | 0 |
PCIB.OL Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PCIB.OL. The Buy consensus is the average rating of analysts ratings from 7 analysts.